Curanex Pharmaceuticals Inc (CURX) stock
CURXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$4.70+0.07 (+1.40%)
Close on Nov 17, 2026Market cap $7.37MP/E –Yield –
Curanex Pharmaceuticals EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Curanex Pharmaceuticals
Curanex Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?